Drug Interaction Assessment Strategies: Small Molecules versus Therapeutic Proteins
Shannon Dallas, Carlo Sensenhauser, Souvik Chattopadhyay, José Silva · Pharmaceutical Sciences Encyclopedia · 2013
Abstract This chapter is not intended to give an expansive and detailed review of all ofthe methods and assays used for drug‐drug interaction (DDI) assessment during small molecule drug (SMD) development because this has already been accomplished by others in the field. Rather, general concepts and methods will be discussed for some of the typical assays undertaken in SMD development, including whether these methods can be, should be, or already have been applied in the context of therapeutic protein (TP)‐DI assessments. This chapter serves as a starting point for understanding the complexity and difficulties in assessing TP‐DIs.